when does semaglutide come off patent A Snapshot of the Landscape 2026-2031 | THE 5-YEAR PLAN

Semaglutide is exclusively patented by Novo Nordisk, and the drugmaker does not supply the ingredient to outside groups, which has raised questions about what other companies are selling to consumers

SUSTAIN 6, a cardiovascular outcomes trial, revealed a 26% reduction in major adverse cardiovascular events (MACE) including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke

Weeks 13+: 2 mg once weekly (maximum) The highest Ozempic dose is 2 mg weekly

GLP-1 medications like semaglutide may help several common challenges of PMOS: Weight management: Even a 5% weight loss can help balance hormones and regulate menstrual cycles

Chronic musculoskeletal pain can last for months or even years, significantly affecting a persons quality of life